Bharat Biotech’s Covaxin safe for children, well-tolerated in 2-18 years age-group: Lancet study

Hyderabad, Jun 18: Bharat Biotech International Limited (BBIL) on Friday announced that its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in paediatric subjects in phase II/III study. A press release from the vaccine maker said the

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News